Pharma group Krka posted record-high sales in 2023

Novo Mesto, 25 January - Pharma group Krka recorded 5% higher sales revenue last year compared to the year before, at EUR 1.81 billion, which is a new record, preliminary unaudited results show. Net profit was down 14% on 2022 due to foreign exchange losses, and amounted to an estimated EUR 311.2 million.